Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen A Boyd

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Addiction (Abingdon, England)|January 20, 2009
Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in GlasgowKathleen A Boyd, Andrew H Briggs
Addiction (Abingdon, England)|May 10, 2016
Cost-effectiveness of financial incentives for smoking cessation in pregnancyKathleen A Boyd, David M Tappin, Linda Bauld
Health Research Policy and Systems|March 12, 2021
Evaluating cancer research impact: lessons and examples from existing reviews on approaches to research impact assessmentCatherine R Hanna, Kathleen A Boyd, Robert J Jones
Human Fertility (Cambridge, England)|June 10, 2023
Setting a tariff for IVF and ICSI treatment: a cost analysisRafael Venson, Abha Maheshwari, Scott M Nelson, et al.
Addiction (Abingdon, England)|September 16, 2015
Are financial incentives cost-effective to support smoking cessation during pregnancy?Kathleen A Boyd, Andrew H Briggs, Linda Bauld, et al.
Contemporary Clinical Trials|July 26, 2011
Power and sample size for cost-effectiveness analysis: fFN neonatal screeningKathleen A Boyd, Andrew H Briggs, Elisabeth Fenwick, et al.
Health Technology Assessment (Winchester, England)|September 15, 2015
Bronchiolitis of Infancy Discharge Study (BIDS): a multicentre, parallel-group, double-blind, randomised controlled, equivalence trial with economic evaluationSteve Cunningham, Aryelly Rodriguez, Kathleen A Boyd, et al.
BMC Psychiatry|January 1, 2015
The feasibility of a randomised controlled trial of Dyadic Developmental PsychotherapyFiona Turner-Halliday, Nicholas Watson, Nicole R S Boyer, et al.
BMC Psychiatry|December 11, 2014
Examining the feasibility of an economic analysis of dyadic developmental psychotherapy for children with maltreatment associated psychiatric problems in the United KingdomNicole R S Boyer, Kathleen A Boyd, Fiona Turner-Halliday, et al.
BMC Pulmonary Medicine|September 11, 2012
Nurse led versus lay educators support for those with asthma in primary care: a costing studyNicola J Roberts, Kathleen A Boyd, Andrew H Briggs, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Addiction (Abingdon, England)|January 20, 2009
Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in GlasgowKathleen A Boyd, Andrew H Briggs
Addiction (Abingdon, England)|May 10, 2016
Cost-effectiveness of financial incentives for smoking cessation in pregnancyKathleen A Boyd, David M Tappin, Linda Bauld
Health Research Policy and Systems|March 12, 2021
Evaluating cancer research impact: lessons and examples from existing reviews on approaches to research impact assessmentCatherine R Hanna, Kathleen A Boyd, Robert J Jones
Human Fertility (Cambridge, England)|June 10, 2023
Setting a tariff for IVF and ICSI treatment: a cost analysisRafael Venson, Abha Maheshwari, Scott M Nelson, et al.
Addiction (Abingdon, England)|September 16, 2015
Are financial incentives cost-effective to support smoking cessation during pregnancy?Kathleen A Boyd, Andrew H Briggs, Linda Bauld, et al.
Contemporary Clinical Trials|July 26, 2011
Power and sample size for cost-effectiveness analysis: fFN neonatal screeningKathleen A Boyd, Andrew H Briggs, Elisabeth Fenwick, et al.
Health Technology Assessment (Winchester, England)|September 15, 2015
Bronchiolitis of Infancy Discharge Study (BIDS): a multicentre, parallel-group, double-blind, randomised controlled, equivalence trial with economic evaluationSteve Cunningham, Aryelly Rodriguez, Kathleen A Boyd, et al.
BMC Psychiatry|January 1, 2015
The feasibility of a randomised controlled trial of Dyadic Developmental PsychotherapyFiona Turner-Halliday, Nicholas Watson, Nicole R S Boyer, et al.
BMC Psychiatry|December 11, 2014
Examining the feasibility of an economic analysis of dyadic developmental psychotherapy for children with maltreatment associated psychiatric problems in the United KingdomNicole R S Boyer, Kathleen A Boyd, Fiona Turner-Halliday, et al.
BMC Pulmonary Medicine|September 11, 2012
Nurse led versus lay educators support for those with asthma in primary care: a costing studyNicola J Roberts, Kathleen A Boyd, Andrew H Briggs, et al.
Pageof 3